Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    21704964 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Characterization of Pseudoxanthoma Elasticum
Condition: Pseudoxanthoma Elasticum
Intervention:
2 Completed Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)
Condition: Choroidal Neovascularization
Intervention: Drug: Intravitreal injection ranibizumab

Indicates status has not been verified in more than two years